Format

Send to

Choose Destination
J Neural Transm (Vienna). 2004 Sep;111(9):1121-39. Epub 2004 May 14.

Effects of piracetam alone and in combination with antiepileptic drugs in rodent seizure models.

Author information

1
Rudolf-Boehm-Institute of Pharmacology and Toxicology, University of Leipzig, Germany. fisw@medizin.uni-leipzig.de

Abstract

The nootropic drug piracetam was investigated in various experimental models of epilepsy. Generally, piracetam exhibits no or only moderate anticonvulsant properties against generalized tonic or clonic seizures. However, in many cases it did increase the anticonvulsant effectiveness of conventional antiepileptics, as shown in the maximal electroshock seizure (MES) threshold test, the traditional MES test or in DBA/2 mice. A pharmacokinetic interaction does not seem to be responsible for this effect. In lethargic mice, a model of absence seizures, piracetam significantly decreased the incidence and duration of spike-wave discharges. Furthermore, in the cobalt-induced focal epilepsy model piracetam reduced the number of spikes/min and in the hippocampal stimulation model it increased the anticonvulsant potency of phenobarbital and phenytoin after single and repeated administration. In conclusion, the well tolerated piracetam itself did not show marked anticonvulsant effects in most screening tests, however, its co-medication with antiepileptic drugs improved seizure protection in various models which may bear potential clinical significance.

PMID:
15338329
DOI:
10.1007/s00702-004-0155-6
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center